{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:43:47Z","timestamp":1790095427852,"version":"4.0.1"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Trichol"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/ijt.ijt_19_20","type":"journal-article","created":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T07:16:37Z","timestamp":1600499797000},"page":"147","source":"Crossref","is-referenced-by-count":26,"title":["Effect of oral minoxidil for alopecia: Systematic review"],"prefix":"10.4103","volume":"12","author":[{"given":"IsraelJunior Borges","family":"do Nascimento","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Harries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"VanessaBarreto","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JacquelineY","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ChunHoong","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HamedKord","family":"Varkaneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nath\u00e1liaSernizon","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AlairJunior","family":"Rocha Arantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MilenaSoriano","family":"Marcolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0974-7753.295406-1","unstructured":"Deborah Pergament, It's not just hair: Historical and cultural considerations for an emerging technology. Chicago Kent Law Rev 1999;75:21."},{"key":"#cr-split#-key-10.4103\/0974-7753.295406-2.1","unstructured":"Hoover E, Alhajj M, Flores JL. Physiology. Hair [Updated 2019 Aug 10]. In: StatPearls [Internet]. Treasure Island, (Florida): StatPearls Publishing"},{"key":"#cr-split#-key-10.4103\/0974-7753.295406-2.2","unstructured":"2020 Jan. Available from: www.ncbi.nlm.nih.gov\/books\/NBK499948. [Last accessed on 2020 Aug 10]."},{"key":"key-10.4103\/0974-7753.295406-3","unstructured":"NYU Langone Health. Types of Hair Loss; 2019. Available from: https:\/\/nyulangone.org\/conditions\/hair-loss\/types. [Last accessed on 2019 Sep 20]."},{"key":"key-10.4103\/0974-7753.295406-4","unstructured":"American Academy of Dermatology. What kids shoudl know about how hair grows. Available from: https:\/\/www.aad.org\/public\/parents-kids\/healthy-habits\/parents\/kids\/hair-grows. Accessed on January 28 2020. [Last accessed on 2020 Aug 10]."},{"key":"key-10.4103\/0974-7753.295406-5","unstructured":"Santos JD. [Characterization of hair before and after of both chemical and physical treatments using Raman spectroscopy, infrared, and electronic microscopy]. PhD Thesis. Federal University of Juiz de Fora: Juiz de Fora, Minas Gerais, Brazil; 2017. Available from: http:\/\/repositorio.ufjf.br:8080\/jspui\/bitstream\/ufjf\/5936\/1\/jordanadiasdossantos.pdf. [Last accessed on 2020 Aug 10]."},{"key":"key-10.4103\/0974-7753.295406-6","unstructured":"Azulay RD. [Dermatology]. 7th ed. Rio de Janeiro: Guanabara Koogan, 2017."},{"key":"key-10.4103\/0974-7753.295406-7","unstructured":"Shapiro J, Hordinsky M. Evaluation and Diagnosis of Hair Loss; 2019. Available from: https:\/\/www.uptodate.com\/contents\/evaluation-and-diagnosis-of-hair-loss#H638362. [Last accessed on 2019 Sep 22]."},{"key":"key-10.4103\/0974-7753.295406-8","unstructured":"U.S. Food and Drug Administration's. Example Drug Facts Label for Minoxidil Topical Solution 2% for Men and Women. U.S. Food and Drug Administration's. Available from: https:\/\/www.fda.gov\/media\/72189\/download. Accessed on January 25 2020. [Last accessed on 2020 Aug 10]."},{"key":"key-10.4103\/0974-7753.295406-9","unstructured":"U.S. Food and Drug Administration's. Highlights of prescribing information-Finasteride U.S. Food and Drug Administration's. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/020788s020s021s023lbl.pdf. Accessed on: January 27 2020. [Last accessed on 2020 Aug 10]."},{"key":"key-10.4103\/0974-7753.295406-10","first-page":"53","volume-title":"A new look at the 5alpha-reductase inhibitor finasteride","author":"Finn","year":"2006","journal-title":"CNS Drug Rev"},{"key":"key-10.4103\/0974-7753.295406-11","first-page":"457","volume-title":"A systematic review of topical finasteride in the treatment of androgenetic alopecia in men and women","author":"Lee","year":"2018","journal-title":"J Drugs Dermatol"},{"key":"key-10.4103\/0974-7753.295406-12","first-page":"e40","volume-title":"Oral minoxidil bio-activation by hair follicle outer root sheath cell sulfotransferase enzymes predicts clinical efficacy in female pattern hair loss","author":"Ramos","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/0974-7753.295406-13","first-page":"132","volume-title":"The history of the development of minoxidil","author":"Zins","year":"1988","journal-title":"Clin Dermatol"},{"key":"key-10.4103\/0974-7753.295406-14","first-page":"221","volume-title":"New treatments for hair loss","author":"Va\u00f1\u00f3-Galv\u00e1n","year":"2017","journal-title":"Actas Dermosifiliogr"},{"key":"key-10.4103\/0974-7753.295406-15","first-page":"63","volume-title":"New-Generation Therapies for the Treatment of Hair Loss in Men","author":"Sadick","year":"2018","journal-title":"Dermatol Clin"},{"key":"key-10.4103\/0974-7753.295406-16","first-page":"252","volume-title":"Use of low-level laser therapy in treatment of the androgenic alopecia, the first systematic review","author":"Najem","year":"2018","journal-title":"J Cosmet Laser Ther"},{"key":"key-10.4103\/0974-7753.295406-17","first-page":"CD007628","volume-title":"Interventions for female pattern hair loss","author":"van","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/0974-7753.295406-18","first-page":"1792","volume-title":"Minoxidil for patchy alopecia areata: Systematic review and meta-analysis","author":"Freire","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/0974-7753.295406-19","first-page":"136","volume-title":"The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis","author":"Adil","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0974-7753.295406-20","first-page":"e1000097","volume-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"key-10.4103\/0974-7753.295406-21","first-page":"210","volume-title":"Rayyan \u2013 A web and mobile app for systematic reviews.Syst Rev","author":"Ouzzani","year":"2016","journal-title":""},{"key":"key-10.4103\/0974-7753.295406-22","first-page":"d5928","volume-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"key-10.4103\/0974-7753.295406-23","unstructured":"Review Manager (RevMan). Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2014."},{"key":"key-10.4103\/0974-7753.295406-24","first-page":"i4919","volume-title":"ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"key-10.4103\/0974-7753.295406-25","unstructured":"StataCorp, Stata Statistical Software: Release 16. College Station, TX: StataCorp LLC; 2019."},{"key":"key-10.4103\/0974-7753.295406-26","first-page":"e12707","volume-title":"Case series of oral minoxidil for androgenetic and traction alopecia: Tolerability & the five C's of oral therapy","author":"Beach","year":"2018","journal-title":"Dermatol Ther"},{"key":"key-10.4103\/0974-7753.295406-27","first-page":"648","volume-title":"Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia","author":"Jimenez-Cauhe","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0974-7753.295406-28","first-page":"AB113","volume-title":"Efficacy and safety of oral minoxidil 5 mg daily during 24-week treatment in male androgenetic alopecia","author":"Lueangarun","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0974-7753.295406-29","first-page":"252","volume-title":"Minoxidil 1 mg oral versus minoxidil 5% solution topically for the treatment of female pattern hair loss: A randomized clinical trial","author":"Ramos","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0974-7753.295406-30","first-page":"32","volume-title":"Androgenetic Alopecia Treatment in Asian Men","author":"Tanaka","year":"2018","journal-title":"J Clin Aesthet Dermatol"},{"key":"key-10.4103\/0974-7753.295406-31","first-page":"104","volume-title":"Female pattern hair loss: A pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone","author":"Sinclair","year":"2018","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/0974-7753.295406-32","first-page":"1488","volume-title":"Evaluation of oral minoxidil in the treatment of alopecia areata","author":"Fiedler-Weiss","year":"1987","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0974-7753.295406-33","doi-asserted-by":"crossref","unstructured":"Wambier CG, Craiglow BG, King BA. Combination tofacitinib and oral minoxidil treatment for severe alopecia areata. J Am Acad Dermatol 2019;S0190-9622(19)32688-X.","DOI":"10.1016\/j.jaad.2019.08.080"},{"key":"key-10.4103\/0974-7753.295406-34","first-page":"1650","volume-title":"Treatment of chronic telogen effluvium with oral minoxidil: A retrospective study","author":"Perera","year":"1000","journal-title":"F"},{"key":"key-10.4103\/0974-7753.295406-35","first-page":"1","volume-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"key-10.4103\/0974-7753.295406-36","first-page":"147","volume-title":"The Medicalization of Society: On the Transformation of Human Conditions into Treatable Disorders - by Conrad P?","author":"Bury","year":"38;","journal-title":"Sociology of Health"},{"key":"key-10.4103\/0974-7753.295406-37","first-page":"355","volume-title":"Minoxidil in severe hypertension with renal failure.Effect of its addition to conventional antihypertensive drugs","author":"Limas","year":"1973","journal-title":"Am J Cardiol"},{"key":"key-10.4103\/0974-7753.295406-38","unstructured":"Center for Drug Evaluation and Research. Pharmacology Review. U.S. Department of Health and Human Services, FDA; 2005."},{"key":"key-10.4103\/0974-7753.295406-39","first-page":"593","volume-title":"Hypertrichosis due to minoxidil.Br J Dermatol","author":"Burton","year":"1979","journal-title":""},{"key":"key-10.4103\/0974-7753.295406-40","unstructured":"Toxicology Data Network, Minoxidil, in U.S National Library of Medicine. TOXNET: United States of America; 2003."},{"key":"key-10.4103\/0974-7753.295406-41","first-page":"396","volume-title":"Absorption of minoxidil after topical application: Effect of frequency and site of application","author":"Eller","year":"1989","journal-title":"Clin Pharmacol Ther"},{"key":"key-10.4103\/0974-7753.295406-42","first-page":"271","volume-title":"Minoxidil acts as an antiandrogen: A study of 5alpha-reductase type 2 gene expression in a human keratinocyte cell line","author":"Pekmezci","year":"2017","journal-title":"Acta Dermatovenerol Croat"},{"key":"key-10.4103\/0974-7753.295406-43","first-page":"17011","volume-title":"Alopecia areata","author":"Pratt","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"key-10.4103\/0974-7753.295406-44","first-page":"1361","volume-title":"Shared decision making: A model for clinical practice","author":"Elwyn","year":"2012","journal-title":"J Gen Intern Med"},{"key":"key-10.4103\/0974-7753.295406-45","first-page":"3","volume-title":"Classifications of patterned hair loss: A review","author":"Gupta","year":"2016","journal-title":"J Cutan Aesthet Surg","ISSN":"https:\/\/id.crossref.org\/issn\/0974-2077","issn-type":"print"},{"key":"key-10.4103\/0974-7753.295406-46","first-page":"1268","volume-title":"SALT II: A new take on the Severity of Alopecia Tool (SALT) for determining percentage scalp hair loss","author":"Olsen","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0974-7753.295406-47","first-page":"440","volume-title":"Alopecia areata investigational assessment guidelines--Part II.National Alopecia Areata Foundation","author":"Olsen","year":"2004","journal-title":"J Am Acad Der matol"},{"key":"key-10.4103\/0974-7753.295406-48","first-page":"109","volume-title":"TrichoScan: A novel tool for the analysis of hair growth in vivo","author":"Hoffmann","year":"2003","journal-title":"J Investig Dermatol Symp Proc"}],"container-title":["International Journal of Trichology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:46:10Z","timestamp":1786733170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijt.ijt_19_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"alternative-id":["295406"],"URL":"https:\/\/doi.org\/10.4103\/ijt.ijt_19_20","relation":{},"ISSN":["0974-7753"],"issn-type":[{"value":"0974-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}